As the deadly coronavirus continues to spread, closing offices and triggering a face-mask frenzy both on the mainland and in Hong Kong, law firms in both places are exercising caution, with many advising their staff to work from home.

A spokesperson for Anglo-American law firm Hogan Lovells told ALB that the firm has extended the Lunar New Year holiday for its employees in Beijing and Shanghai until Feb, 9, in line with the Chinese government’s instructions. The firm will then implement flexible working hours depending on local conditions.

Herbert Smith Freehills’ Beijing and Shanghai offices will also be extending their LNY closure, reopening on Feb. 3, with staff in Shanghai to work from home until Feb. 10. Simon Chapman, a partner in Hong Kong, said the team was continuing to monitor the situation closely. “We have robust business continuity plans in place and our crisis and operations teams are assessing and implementing recommendations by authorities in each country affected,” he said. 

In line with advice from the Hong Kong government, Chapman said that staff based in the city were being encouraged to work from home for the remainder of the week, with the office slated to open as normal on Feb. 3. “Given the fluidity of the situation, we will review these operational arrangements against the current situation at the end of the week,” he said.

One issue that employers – including law firms – need to be careful about at this time is the collection of data related to employees’ health. According to employment-focused law firm Hugill & Ip, employers must only gather information if it is for a purpose “directly related to the assessment of suitability of the employee’s continuance in employment; or directly related to the employer’s administration of medical or other benefits or compensation provided to the employee.”

“An employer may only need the minimum information about a sick leave application of an employee to verify or calculate the entitlement to sick leave and other related benefits but not the details of the treatment prescribed for the medical condition afflicting the employee,” said partner Carmen Tang. 

 

To contact the editorial team, please email ALBEditor@thomsonreuters.com. 

Related Articles

EXPLAINER: Does Covishield’s alleged health concerns expose it to legal liability?

by Nimitt Dixit |

COVID-19 vaccine-maker AstraZeneca was in the spotlight in May following the company’s admission in a UK court proceeding of the possibility of a rare side effect, Thrombosis with Thrombocytopenia Syndrome (TTS) associated with its vaccines. More than 50 individuals have alleged the vaccine resulted in death and serious injuries from TTS.  

BRIEFS: Faltering Chinese Recovery Leaves Hong Kong Short of IPOs, But Hope Remains

by Sarah Wong |

Shaking off the COVID-19 shadow after three isolated years, Hong Kong is now gripped by a fresh challenge as subdued markets sap the appetite for fundraising activities. With weak global demands and domestic headwinds putting a dent in China's much-hyped reopening, Hong Kong's capital markets have been struggling to take off.

Raring To Go

by Sarah Wong |

Reopened borders, scrapped restrictions, and conciliatory policies have come as relief to PRC law firms in Hong Kong, with economic activities in Greater China expected to steadily pick up following a difficult pandemic period. While lawyers are wary of an uncertain regulatory landscape and moderate investor confidence, they are also banking on their unique positioning as a bridge between China and the rest of the world.